{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:21:58Z","timestamp":1792027318575,"version":"4.4.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T00:00:00Z","timestamp":1379462400000},"content-version":"vor","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jacc.2012.01.077","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T18:02:44Z","timestamp":1343239364000},"page":"1031-1042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":381,"title":["Cardiorenal Syndrome Type 1"],"prefix":"10.1016","volume":"60","author":[{"given":"Claudio","family":"Ronco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariantonietta","family":"Cicoira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2012.01.077_bib1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.01.077_bib2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/ndt\/gfq180","article-title":"Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference","volume":"25","author":"McCullough","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2012.01.077_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000313745","article-title":"Cardiorenal syndromes: an executive summary from the Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"165","author":"Ronco","year":"2010","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.jacc.2012.01.077_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/eurjhf\/hfp169","article-title":"Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure population","volume":"12","author":"Hata","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2012.01.077_bib5","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/ndt\/gfq066","article-title":"Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference","volume":"25","author":"Bagshaw","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2012.01.077_bib6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cardfail.2007.04.008","article-title":"Worsening renal function and prognosis in heart failure: systematic review and meta-analysis","volume":"13","author":"Damman","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2012.01.077_bib7","first-page":"762590","article-title":"Cardiorenal syndromes: pathophysiology to prevention","volume":"2010","author":"McCullough","year":"2010","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.jacc.2012.01.077_bib8","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/gfq136","article-title":"Definition and classification of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference","volume":"25","author":"House","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2012.01.077_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.soard.2008.07.011","article-title":"Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein","volume":"5","author":"Agrawal","year":"2009","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jacc.2012.01.077_bib10","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/j.1582-4934.2010.01141.x","article-title":"The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease","volume":"14","author":"Ouwens","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib11","first-page":"89","article-title":"Obesity is associated with left atrial enlargement, E\/A reversal and left ventricular hypertrophy","volume":"13","author":"Movahed","year":"2008","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.mnh.0000242172.06459.7c","article-title":"Obesity, proteinuria and progression of renal failure","volume":"15","author":"Praga","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jacc.2012.01.077_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MNH.0b013e3283374c09","article-title":"Scope and mechanisms of obesity-related renal disease","volume":"19","author":"Hunley","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jacc.2012.01.077_bib14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/ALN.0b013e3181eff32e","article-title":"Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery","volume":"113","author":"Glance","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jacc.2012.01.077_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/cyto.2001.0918","article-title":"High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients","volume":"15","author":"Cicoira","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.jacc.2012.01.077_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3909\/ricm0581","article-title":"Clinical impact of renal dysfunction in heart failure","volume":"12","author":"Palazzuoli","year":"2011","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000321853","article-title":"Micronutrients and cardiorenal disease: insights into novel assessments and treatment","volume":"31","author":"McCullough","year":"2011","journal-title":"Blood Purif"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2012.01.077_bib18","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1053\/j.ajkd.2007.12.017","article-title":"CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999\u20132004","volume":"51","author":"McCullough","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2012.01.077_bib19","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1517\/14656566.2010.485612","article-title":"Hypertensive nephropathy: prevention and treatment recommendations","volume":"11","author":"Hart","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jacc.2012.01.077_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","article-title":"Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure","volume":"43","author":"Forman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1053\/j.ajkd.2010.05.017","article-title":"Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study","volume":"56","author":"Warnock","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2012.01.077_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.ajkd.2011.02.391","article-title":"High-normal albuminuria and risk of heart failure in the community","volume":"58","author":"Blecker","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2012.01.077_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(09)61378-7","article-title":"Albuminuria in chronic heart failure: prevalence and prognostic importance","volume":"374","author":"Jackson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.01.077_bib24","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1046\/j.1523-1755.2001.00053.x","article-title":"Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function","volume":"60","author":"Periyasamy","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2012.01.077_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000313846","article-title":"Uremia aggravates left ventricular remodeling after myocardial infarction","volume":"32","author":"Dikow","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jacc.2012.01.077_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11906-001-0038-2","article-title":"Hyperuricemia and renal function","volume":"3","author":"Ruilope","year":"2001","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacc.2012.01.077_bib27","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib28","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/archinternmed.2010.198","article-title":"Gout, allopurinol use, and heart failure outcomes","volume":"170","author":"Thanassoulis","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib29","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(10)60391-1","article-title":"Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial","volume":"375","author":"Noman","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.01.077_bib30","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01580210","article-title":"Effect of allopurinol in chronic kidney disease progression and cardiovascular risk","volume":"5","author":"Goicoechea","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2012.01.077_bib31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10741-010-9194-2","article-title":"The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome","volume":"16","author":"Silverberg","year":"2011","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2012.01.077_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5301\/IJAO.2011.6314","article-title":"Relationship between erythropoietin responsiveness, insulin resistance, and malnutrition-inflammation-atherosclerosis (MIA) syndrome in hemodialysis patients with diabetes","volume":"34","author":"Abe","year":"2011","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jacc.2012.01.077_bib33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10741-011-9230-x","article-title":"Anemia in cardio-renal syndrome: clinical impact and pathophysiologic mechanisms","volume":"16","author":"Palazzuoli","year":"2011","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2012.01.077_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2217\/fca.10.97","article-title":"Increased hepcidin-25 and erythropoietin responsiveness in patients with cardio-renal anemia syndrome","volume":"6","author":"Kato","year":"2010","journal-title":"Future Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurjhf\/hfq099","article-title":"Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease\/chronic heart failure patients","volume":"12","author":"van der Putten","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2012.01.077_bib36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1755-6686.2010.00164.x","article-title":"Anaemia management in cardio renal disease","volume":"36","author":"Silverberg","year":"2010","journal-title":"J Ren Care"},{"key":"10.1016\/j.jacc.2012.01.077_bib37","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MNH.0b013e3283428bc2","article-title":"Critical appraisal of randomized controlled trials of anemia correction in patients with renal failure","volume":"20","author":"Parfrey","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jacc.2012.01.077_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2217\/bmm.11.49","article-title":"Neutrophil gelatinase-associated lipocalin: a superior biomarker for detection of subclinical acute kidney injury and poor prognosis","volume":"5","author":"Haase","year":"2011","journal-title":"Biomark Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib40","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jacc.2010.11.051","article-title":"The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies","volume":"57","author":"Haase","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/cvr\/cvq308","article-title":"Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart","volume":"89","author":"Creemers","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2012.01.077_bib42","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3909\/ricm0624","article-title":"Galectin-3: a novel blood test for the evaluation and management of patients with heart failure","volume":"12","author":"McCullough","year":"2011","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib43","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacc.2012.01.077_bib44","first-page":"305","article-title":"Galectin-3 as a multifunctional protein","volume":"9","author":"Krze\u015blak","year":"2004","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.jacc.2012.01.077_bib45","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s003359900548","article-title":"Mapping of the galectin-3 gene (LGALS3) to human chromosome 14 at region 14q21-22","volume":"8","author":"Raimond","year":"1997","journal-title":"Mamm Genome"},{"key":"10.1016\/j.jacc.2012.01.077_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-065X.2009.00794.x","article-title":"The regulation of inflammation by galectin-3","volume":"230","author":"Henderson","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jacc.2012.01.077_bib47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MNH.0b013e328344c3d4","article-title":"Mechanisms of fibrosis: the role of the pericyte","volume":"20","author":"Schrimpf","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jacc.2012.01.077_bib48","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.01.077_bib49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10741-005-6129-4","article-title":"The cardiorenal syndrome: lessons from the ADHERE database and treatment options","volume":"9","author":"Heywood","year":"2004","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2012.01.077_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/eurheartj\/ehi020","article-title":"The severe cardiorenal syndrome: \u2018Guyton revisited\u2019","volume":"26","author":"Bongartz","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.01.077_bib51","first-page":"612","article-title":"The influence of venous pressure on the isolated mammalian kidney","volume":"463","author":"Winton","year":"1931","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib52","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib53","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jacc.2007.08.072","article-title":"Cardiorenal interactions: insights from the ESCAPE trial","volume":"51","author":"Nohria","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2012.01.077_bib54","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/01.CCM.0000296270.41256.5C","article-title":"Acute decompensated heart failure and the cardiorenal syndrome","volume":"36","author":"Liang","year":"2008","journal-title":"Crit Care Med"},{"issue":"Suppl 5","key":"10.1016\/j.jacc.2012.01.077_bib55","first-page":"IV90","article-title":"Neurohumoral activation in preclinical heart failure","volume":"87","author":"Francis","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.01.077_bib56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000320359","article-title":"Angiotensin II and its role in tubular epithelial to mesenchymal transition associated with chronic kidney disease","volume":"193","author":"Burns","year":"2011","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.jacc.2012.01.077_bib57","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0735-1097(01)01237-2","article-title":"Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype","volume":"37","author":"Cicoira","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9149(01)02261-5","article-title":"Relation of aldosterone \u201cescape\u201d despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"89","author":"Cicoira","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib59","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","article-title":"Galectin-3: a novel mediator of heart failure development and progression","volume":"11","author":"de Boer","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2012.01.077_bib60","first-page":"183","article-title":"Pathogenesis of ascites and renal salt retention in cirrhosis","volume":"47","author":"Palmer","year":"1999","journal-title":"J Investig Med"},{"issue":"54","key":"10.1016\/j.jacc.2012.01.077_bib61","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications","volume":"3","author":"Triposkiadis","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib62","first-page":"543","article-title":"Neural regulation of renin secretion","volume":"13","author":"Kopp","year":"1993","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jacc.2012.01.077_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib64","doi-asserted-by":"crossref","first-page":"3C","DOI":"10.1016\/j.amjcard.2005.03.006","article-title":"Immune activation in chronic heart failure","volume":"95","author":"Torre-Amione","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib65","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.CIR.92.6.1479","article-title":"Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure","volume":"92","author":"Ferrari","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.01.077_bib66","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0002-9149(98)00872-8","article-title":"Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"83","author":"Aukrust","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib67","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST)","volume":"103","author":"Deswal","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.01.077_bib68","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.vph.2006.08.011","article-title":"The long pentraxin PTX3 in vascular pathology","volume":"45","author":"Mantovani","year":"2006","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jacc.2012.01.077_bib69","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ncpcardio0938","article-title":"Mechanisms of disease: toll-like receptors in cardiovascular disease","volume":"4","author":"Frantz","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib70","doi-asserted-by":"crossref","first-page":"17C","DOI":"10.1016\/j.amjcard.2005.03.008","article-title":"Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches","volume":"95","author":"Gullestad","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib71","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.01.077_bib72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-5273(02)00470-9","article-title":"How to RECOVER from RENAISSANCE?","volume":"86","author":"Anker","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurjhf\/hfn043","article-title":"Inflammation as a therapeutic target in heart failure?","volume":"11","author":"Heymans","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2012.01.077_bib74","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1161\/01.CIR.102.25.3060","article-title":"Plasma cytokine parameters and mortality in patients with chronic heart failure","volume":"102","author":"Rauchhaus","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.01.077_bib75","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0002-9149(03)00545-9","article-title":"Inflammatory and neurohormonal activation in cardiogenic pulmonary edema: implications on the pathogenesis and outcome of acute ischemic versus non-ischemic acute heart failure","volume":"92","author":"Milo","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib76","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.CIR.0000151611.89232.3B","article-title":"Endothelial cell activation in patients with decompensated heart failure","volume":"111","author":"Colombo","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.01.077_bib77","doi-asserted-by":"crossref","first-page":"L685","DOI":"10.1152\/ajplung.00247.2005","article-title":"Mechanisms of pulmonary edema clearance","volume":"289","author":"Mutlu","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib78","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejheart.2008.01.007","article-title":"Fluid overload in acute heart failure: re-distribution and other mechanisms beyond fluid accumulation","volume":"10","author":"Cotter","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2012.01.077_bib79","first-page":"632","article-title":"The emerging role of the gut in chronic heart failure","volume":"11","author":"Sandek","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jacc.2012.01.077_bib80","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/00005373-199905000-00021","article-title":"Tumor necrosis factor depresses myocardial contractility in endotoxemic swine","volume":"46","author":"Kraut","year":"1999","journal-title":"J Trauma"},{"key":"10.1016\/j.jacc.2012.01.077_bib81","first-page":"R265","article-title":"Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility","volume":"276","author":"Kumar","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib82","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00003246-199907000-00018","article-title":"Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function","volume":"27","author":"Cain","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib83","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amjmed.2010.11.014","article-title":"Incidence of cardiovascular events after hospital admission for pneumonia","volume":"124","author":"Perry","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib84","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ki.2009.502","article-title":"Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival","volume":"77","author":"Murugan","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2012.01.077_bib85","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.diabres.2011.07.021","article-title":"Metformin-associated lactic acidosis in a patient with normal kidney function","volume":"96","author":"van Sloten","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jacc.2012.01.077_bib86","doi-asserted-by":"crossref","first-page":"749653","DOI":"10.4061\/2011\/749653","article-title":"Metformin-associated acute kidney injury and lactic acidosis","volume":"2011","author":"Arroyo","year":"2011","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.jacc.2012.01.077_bib87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/07853890510007205","article-title":"Acute renal failure in cancer patients","volume":"37","author":"Lameire","year":"2005","journal-title":"Ann Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib88","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4067\/S0034-98872011000400014","article-title":"[The role of uric acid in heart failure]","volume":"139","author":"Alca\u00edno","year":"2011","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.jacc.2012.01.077_bib89","doi-asserted-by":"crossref","first-page":"R172","DOI":"10.1186\/cc10318","article-title":"Oliguria as predictive biomarker of acute kidney injury in critically ill patients","volume":"15","author":"Prowle","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jacc.2012.01.077_bib90","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000142938","article-title":"Radiocontrast-induced acute kidney injury","volume":"109","author":"McCullough","year":"2008","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib91","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.jacc.2009.12.051","article-title":"Contrast-induced acute kidney injury","volume":"55","author":"Mehran","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib92","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2009.07.020","article-title":"Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis","volume":"54","author":"Haase","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2012.01.077_bib93","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2215\/CJN.06140710","article-title":"Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward","volume":"6","author":"Alvelos","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2012.01.077_bib94","first-page":"Si","article-title":"Volume overload and cardiorenal syndromes","volume":"16","author":"Ronco","year":"2010","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jacc.2012.01.077_bib95","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/eurjhf\/hfr126","article-title":"Clinical trials in acute heart failure: simpler solutions to complex problems","volume":"13","author":"McDonagh","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2012.01.077_bib96","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejheart.2005.04.014","article-title":"Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction","volume":"8","author":"Westendorp","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2012.01.077_bib97","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ejheart.2008.07.013","article-title":"Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials","volume":"10","author":"Scott","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2012.01.077_bib98","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrneph.2009.213","article-title":"Fluid balance and acute kidney injury","volume":"6","author":"Prowle","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacc.2012.01.077_bib99","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/clc.20771","article-title":"Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue","volume":"33","author":"Chiong","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000164149","article-title":"Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry","volume":"113","author":"Peacock","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2012.01.077_bib101","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib102","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.semnephrol.2011.11.015","article-title":"Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome","volume":"32","author":"Ronco","year":"2012","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jacc.2012.01.077_bib103","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1755-8794-2-2","article-title":"Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases","volume":"2","author":"Kell","year":"2009","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jacc.2012.01.077_bib104","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4244\/V5I3A53","article-title":"Serum catalytic iron as a novel biomarker of vascular injury in acute coronary syndromes","volume":"5","author":"Lele","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2012.01.077_bib105","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3109\/03630260903212233","article-title":"The role of labile iron in kidney disease and treatment with chelation","volume":"33","author":"Shah","year":"2009","journal-title":"Hemoglobin"},{"key":"10.1016\/j.jacc.2012.01.077_bib106","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3909\/ricm0555","article-title":"The role of oxidative stress in the metabolic syndrome","volume":"12","author":"Whaley-Connell","year":"2011","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib107","first-page":"72","article-title":"B-type natriuretic peptides: a diagnostic breakthrough for clinicians","volume":"4","author":"McCullough","year":"2003","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jacc.2012.01.077_bib108","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/clc.20787","article-title":"Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction","volume":"33","author":"Sica","year":"2010","journal-title":"Clin Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2012.01.077_bib109","first-page":"S25","article-title":"Early biomarkers of renal injury","volume":"16","author":"Cruz","year":"2010","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jacc.2012.01.077_bib110","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1172\/JCI23056","article-title":"Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury","volume":"115","author":"Mori","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2012.01.077_bib111","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.jacc.2009.12.046","article-title":"Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury","volume":"55","author":"Haase","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.01.077_bib112","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/eurjhf\/hfr087","article-title":"Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial","volume":"13","author":"Maisel","year":"2011","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712019559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712019559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:53:16Z","timestamp":1760014396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109712019559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":112,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0735109712019559"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2012.01.077","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiorenal Syndrome Type 1","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2012.01.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}